10 Recruiting Studies Using Gemtuzumab Ozogamicin
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Gemtuzumab Ozogamicin
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
📍 Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
Acute Myeloid Leukemia
View Study & Checklist ➔Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
📍 Fred Hutchinson Cancer Center/University of Washington Cancer Consortium — Seattle, Washington
Acute Myeloid Leukemia
View Study & Checklist ➔Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
View Study & Checklist ➔Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
📍 Memorial Hospital West — Pembroke Pines, Florida
Core Binding Factor Acute Myeloid Leukemia
View Study & Checklist ➔CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
📍 Moffitt Cancer Center — Tampa, Florida
Acute Myeloid Leukemia
View Study & Checklist ➔Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Acute Promyelocytic Leukemia With PML-RARA
View Study & Checklist ➔A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
📍 Phoenix Children's Hospital — Phoenix, Arizona
Acute Myeloid Leukemia
View Study & Checklist ➔